APA (7th ed.) Citation

S, B., T, B., & M, O. (2026). Evolving treatment strategies for HER2-altered non-small-cell lung cancer: The rise of TKIs and ADCs. Frontiers in oncology, 16, 1771869. https://doi.org/10.3389/fonc.2026.1771869

Chicago Style (17th ed.) Citation

S, Balli, Basoglu T, and Ozdogan M. "Evolving Treatment Strategies for HER2-altered Non-small-cell Lung Cancer: The Rise of TKIs and ADCs." Frontiers in Oncology 16 (2026): 1771869. https://doi.org/10.3389/fonc.2026.1771869.

MLA (9th ed.) Citation

S, Balli, et al. "Evolving Treatment Strategies for HER2-altered Non-small-cell Lung Cancer: The Rise of TKIs and ADCs." Frontiers in Oncology, vol. 16, 2026, p. 1771869, https://doi.org/10.3389/fonc.2026.1771869.